CI
stock Healthcare Healthcare PlansOverall Mixed · 50%
- Fundamentals Fair
- Trajectory Climbing
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Bearish 0 of 5 trend signals bullishRSI 40 — soft momentum, not yet oversold.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $270.87
- -0.68%
- Close
- $270.87
- -0.68%
- Current
- $270.87
- Prev close
- $272.72
- Today
- 975.78K
- 3-mo avg
- 1.67M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- Apr 3082 days ago
- Next expected
- Jul 30in 9 days
Recent earnings dates
- Apr 30 82 days ago
- Feb 5 166 days ago
- Oct 30, 2025 264 days ago
- Jul 31, 2025 355 days ago
Past earnings dates come from CI’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), CI’s fundamentals read as fair overall.
At 11.5x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.2% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 2.2% margin is thin; little of each revenue dollar survives as profit.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 14.3% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 3.8% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 2.78, the company leans heavily on borrowing, which adds risk if results weaken.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.85, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 11.2% from the prior year: strong top-line expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 73.5% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $174.1B | $180.5B | $195.3B | $247.1B | $274.9B |
| Net income | $5.4B | $6.8B | $5.2B | $3.4B | $6.0B |
| Diluted EPS | $15.75 | $21.41 | $17.39 | $12.12 | $22.18 |
| Dividend / share | $4.00 | $4.48 | $4.92 | $5.60 | $6.04 |
| Total assets | $154.9B | $143.9B | $152.8B | $155.9B | $157.9B |
| Total liabilities | $107.7B | $99.1B | $106.4B | $114.6B | $116.0B |
| Shareholder equity | $47.0B | $44.7B | $46.2B | $41.0B | $41.7B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.5B | $63.7B | $65.6B | $65.5B | $67.2B | $69.7B | $72.5B | $68.5B |
| Net income | $1.6B | $825.0M | $1.2B | $1.3B | $1.6B | $2.0B | $1.0B | $1.7B |
| Diluted EPS | $5.45 | $2.63 | $5.01 | $4.85 | $5.71 | $6.98 | $4.64 | $6.26 |
| Dividend / share | $1.40 | $1.40 | $1.40 | $1.51 | $1.51 | $1.51 | $1.51 | $1.56 |
Leadershipsynced from SEC 58d ago
- Cordani David Chairman & CEO · Director
- Dennison Ann M EVP, CFO
- Brailer David J EVP & Chief Health Officer
- Evanko Brian C See Remarks
- Jones Nicole S See Remarks
- Kates Jamie G Chief Accounting Officer
- Koka Durga Prasad EVP, Global CIO
- Nelson Andrea L EVP, General Counsl & Corp Sec
- Neville Everett See Remarks
- Foss Eric J Director
- Hathi Neesha Director
- Hennigan Michael J Director
- Kurian George Director
- Mazzarella Kathleen M Director
- Mcclellan Mark B. Director
- Ozuah Philip Director
- Ross Kimberly A. Director
- Wiseman Eric C Director
- Zarcone Donna F Director
Officers and board are drawn from CI’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- Mar 3 Officer or director change reported in an 8-K
- Dec 31, 2025 FY2025 net income +73% YoY
- Nov 3, 2025 +5.8% one-day move
- Oct 30, 2025 New 6-month low (-26% off peak)
- Oct 30, 2025 −17.4% one-day move
- Oct 20, 2025 Officer or director change reported in an 8-K
- Jul 31, 2025 New 6-month low (-21% off peak)
- Jul 31, 2025 −10.2% one-day move
- Jul 28, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $6.04
- 2026 so far
- $1.561 payment
- 2026 projected
- $6.24+3.3% vs 2025
Projection scales CI’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 5 $1.56
- Dec 4, 2025 $1.51
- Sep 4, 2025 $1.51
- Jun 3, 2025 $1.51
- Mar 5, 2025 $1.51
- Dec 4, 2024 $1.40
- Sep 4, 2024 $1.40
- Jun 4, 2024 $1.40
- Mar 5, 2024 $1.40
- Dec 5, 2023 $1.23
- Sep 5, 2023 $1.23
- Jun 6, 2023 $1.23
- Mar 7, 2023 $1.23
- Dec 5, 2022 $1.12
- Sep 6, 2022 $1.12
- Jun 7, 2022 $1.12
- Mar 8, 2022 $1.12
- Dec 6, 2021 $1.00
- Sep 7, 2021 $1.00
- Jun 7, 2021 $1.00
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K/A Current report (amended)